Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy

Wong, ED; Nester, C; Cavero, T; Karras, A; Le Quintrec, M; Lightstone, L; Eisenberger, U; Soler, MJ; Kavanagh, D; Daina, E; Praga, M; Medjeral-Thomas, NR; Gäckler, A; Garcia-Carro, C; Biondani, A; Chaperon, F; Kulmatycki, K; Milojevic, J; Webb, NJA; Nidamarthy, PK; Junge, G; Remuzzi, G

Wong, ED (通讯作者),Royal Victoria Infirm, Natl Renal Complement Therapeut Ctr, Bldg 26,Queen Victoria Rd, Newcastle Upon Tyne NE1 4LP, England.

KIDNEY INTERNATIONAL REPORTS, 2023; 8 (12): 2754

Abstract

Introduction: Complement 3 glomerulopathy (C3G) is a rare inflammatory kidney disease mediated by dysregulation of the alternative complement pathway.......

Full Text Link